News

Actavis buying Durata Therapeutics for $616.4M

By Sun-Times Wire

Specialty pharmaceutical company Actavis is buying Chicago-based Durata Therapeutics Inc. for about $616.4 million to help bolster its infectious disease portfolio. One of Durata’s key products is Dalvance for injection, an IV antibiotic for acute bacterial skin and skin structure infections. Dalvance was approved by the Food and Drug Administration in May.

Read more at Newsfeed.

Next Up In News

Netflix looks to curb password sharing, considers ads

Aiming to predict COVID, future pandemics better, CDC opens infectious diseases forecasting center

Joliet farmers wrangle cows thrown from semitrailer after crash on Interstate 80

1 killed, 3 wounded in shootings Tuesday in Chicago

Obama relatives sue Milwaukee school alleging racial bias

Unmasked transit: Pritzker ends mask mandates in public transportation, airports

The Latest

Bears

Bears vs. Broncos — What to Watch 4

The Bears’ running game hasn’t been as potent as it was last season when they led the NFL in rushing yards. But it has a chance to step it up against a Broncos defense that allowed 350 rushing yards to the Dolphins last week.

By Mark Potash

Cubs

Wrap up the baseball season with a year-end trivia challenge

It’s time to take stock of how much you learned from — and enjoyed — our weekly quizzes

By Bill Chuck

Dear Abby

Dear Abby: Co-worker’s now my boss, and I’m jealous

Employee wanted the promotion that instead went to someone with less experience.

By Abigail Van Buren

Rafiah Maxie-Cole (left) holds a photo of her son, Jamal Clay, and Valencia Sagnia shows a portrait of her brother, Marquist Spivey, both of whom died by suicide. The women have each started mental health programs that offer mental health education directed toward Black communities among others.

Health

Black Cook County residents face scarcity of mental health resources as their suicide rates remain high after the pandemic

The county’s Black residents are the only racial group whose suicide rates are higher now than before the pandemic.

By Mariah Rush

Bears

Justin Fields has low bar to clear vs. Broncos

Bears offensive coordinator Luke Getsy says comparisons to other developing quarterbacks is “not apples to apples.” But is it too much to ask Fields to be as good against the Broncos’ defense as the Commanders’ Sam Howell was in Week 2?

By Mark Potash